Improvement of leukemia-free survival (ITS) and reduction of relapse incidence by allogeneic stem cell transplantation (SCT) in elderly patients (pts) with AML, irrespective of the FLT3-ITD and npm status except npm+/flt3(ITD)-

被引：0
|
作者：
Niederwieser, O.
Schueler, F.
Hegenbart, U.
Maschmeyer, G.
Fischer, T.
Junghanss, C.
Wolf, H.
Sayer, H. G.
Kreibich, U.
Doelken, G.
机构：
[1] Univ Leipzig, Dept Hematol Oncol & Hemostasis, D-04109 Leipzig, Germany
[2] Univ Hosp, Leipzig, Germany
[3] Amyloidosis Ctr, Heidelberg, Germany
[4] Potsdam Klinikum, Potsdam, Germany
[5] Univ Magdeburg, D-39106 Magdeburg, Germany
[6] Univ Rostock, D-18055 Rostock, Germany
[7] Univ Halle Wittenberg, D-06108 Halle, Germany
[8] Jena Uniklinikum, Jena, Germany
[9] Braun Krankenhaus, Zwickau, Germany
[10] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6505
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The value of allogeneic stem cell transplantation in patients with intermediate risk (ELN) Acute Myeloid Leukemia with no FLT3-ITD, no NPM1 mutations and no CEBPA double mutations
    Heidrich, K.
    Thiede, C.
    Schaefer-Eckart, K.
    Schmitz, N.
    Aulitzky, W. E.
    Kraemer, A.
    Roesler, W.
    Haenel, M.
    Einsele, H.
    Baldus, C. D.
    Trappe, R. U.
    Stoelzel, F.
    Middeke, J. M.
    Roellig, C.
    Taube, F.
    Kramer, M.
    Serve, H.
    Berdel, W. E.
    Ehninger, G.
    Bornhaeuser, M.
    Schetelig, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 28 - 28
  • [32] The Comparative Value of Hematopoietic Stem Cell Transplantation and Chemotherapy in Cytogenetically Normal AML Subclassified By NPM1 Mutation Status and FLT3-ITD Allelic Ratio
    Versluis, Jurjen
    Devillier, Raynier
    In't Hout, Florentien
    van Putten, Wim
    Manz, Markus G.
    Vekemans, Marie-Christianne
    Schaafsma, Martyn Ronald
    Passweg, Jakob R.
    Maertens, Johan
    Kuball, Jurgen H.
    Verdonck, Leo F.
    Biemond, Bart J.
    Valk, Peter J. M.
    Mozziconacci, Marie-Joelle
    Vey, Norbert
    Schouten, Harry C.
    Vellenga, Edo
    Pabst, Thomas
    Lowenberg, Bob
    Ossenkoppele, Gert J.
    Blaise, Didier
    Huls, Gerwin A.
    Cornelissen, Jan J.
    BLOOD, 2014, 124 (21)
  • [33] Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations
    Heidrich, K.
    Thiede, C.
    Schaefer-Eckart, K.
    Schmitz, N.
    Aulitzky, W. E.
    Kraemer, A.
    Roesler, W.
    Haenel, M.
    Einsele, H.
    Baldus, C. D.
    Trappe, R. U.
    Stoelzel, F.
    Middeke, J. M.
    Roellig, C.
    Taube, F.
    Kramer, M.
    Serve, H.
    Berdel, W. E.
    Ehninger, G.
    Bornhaeuser, M.
    Schetelig, J.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2793 - 2798
  • [34] Measurable Residual Disease Status and FLT3 Inhibitor Therapy in Patients with FLT3-ITD-Mutated AML Following Allogeneic Hematopoietic Cell Transplantation
    Liang, Emily C.
    Chen, Connie
    Lu, Rong
    Mannis, Gabriel N.
    Muffly, Lori
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S278 - S279
  • [35] FLT3-ITD and CEBPA Mutations Predict Prognosis in Acute Myelogenous Leukemia Irrespective of Hematopoietic Stem Cell Transplantation
    Wang, Hong
    Chu, Tian-Tian
    Han, Shi-Yun
    Qi, Jia-Qian
    Tang, Ya-Qiong
    Qiu, Hui-Ying
    Fu, Cheng-Cheng
    Tang, Xiao-Wen
    Ruan, Chang-Geng
    Wu, De-Pei
    Han, Yue
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (05) : 941 - 948
  • [36] Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with FLT3-ITD AML
    Chen, Yi-Bin
    Shuli, Li
    Andrew, Lane A.
    Connolly, Christine
    Del Rio, Candice
    Valles, Betsy
    Curtis, Morgan
    Ballen, Karen K.
    Cutler, Corey S.
    Dey, Bimalangshu R.
    El-Jawahri, Areej
    Fathi, Amir T.
    Ho, Vincent T.
    Joyce, Amy
    McAfee, Steven L.
    Rudek, Michelle A.
    Rajkhowa, Trivikram
    Verselis, Sigitas
    Antin, Joseph H.
    Spitzer, Thomas R.
    Levis, Mark
    Soiffer, Robert J.
    BLOOD, 2014, 124 (21)
  • [37] A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation
    Miguel Waterhouse
    Hartmut Bertz
    Juergen Finke
    Annals of Hematology, 2014, 93 : 293 - 298
  • [38] A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation
    Waterhouse, Miguel
    Bertz, Hartmut
    Finke, Juergen
    ANNALS OF HEMATOLOGY, 2014, 93 (02) : 293 - 298
  • [39] Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemia
    Aldoss, Ibrahim
    Nakamura, Ryotaro
    Yang, Dongyun
    Salhotra, Amandeep
    Stein, Anthony S.
    Pullarkat, Vinod
    Forman, Stephen J.
    Marcucci, Guido
    BONE MARROW TRANSPLANTATION, 2020, 55 (02) : 473 - 475
  • [40] Favorable outcomes for allogeneic hematopoietic cell transplantation in elderly patients with NPM1-mutated and FLT3-ITD-negative acute myeloid leukemia
    Ibrahim Aldoss
    Ryotaro Nakamura
    Dongyun Yang
    Amandeep Salhotra
    Anthony S. Stein
    Vinod Pullarkat
    Stephen J. Forman
    Guido Marcucci
    Bone Marrow Transplantation, 2020, 55 : 473 - 475
12345